Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The Toxic Avenger Mops up at Least $5 Million of Health Bills -- Cineverse Forgoes New Marketing Stunts in Favor of Partnership with National Non-profit Undue Medical Debt

Courtesy of Cineverse (PRNewsfoto/Cineverse Corp.)

News provided by

Cineverse Corp.

Aug 27, 2025, 12:00 ET

Share this article

Share toX

Share this article

Share toX

An Additional $1 Million of Burdonsome Health Debt Gets Nuked for Every Million Dollars at the Domestic Box Office

LOS ANGELES, Aug. 27, 2025 /PRNewswire/ -- Move over, superheroes — there's a new kind of vigilante in town, and he's armed with a radioactive mop. When The Toxic Avenger storms theaters this weekend, he won't just be melting faces on screen — he'll be melting medical debt in real life.

In The Toxic Avenger, the new unrated horror/comedy written and directed by Macon Blair (I Don't Feel At Home in This World Anymore, writer for Marvel Comics/Dark Horse Comics), Toxie has his life upended by unexpected medical debt.

So after thrilling fans at Comic-Con, bringing the Moviefone number back from the dead, warning teens about the dangers of high-sugar soda, cleaning up Los Angeles on Earth Day and so on … The team behind The Toxic Avenger has announced that any further marketing stunts are canceled, and the rest of their budget will be spent on something more important than radioactive justice.

SEE THE SCRAPPED STUNTS HERE.

Here's the deal: at least $5 million in medical debt gets erased no matter what. And for every million bucks the movie makes at the box office, another million in debt will go up in toxic smoke.

This debt relief is possible thanks to a partnership between Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, and Undue Medical Debt, a national nonprofit dedicated to helping families least able to pay burdensome healthcare debt.

"We spent hours brainstorming how to close out the campaign and, while sending Toxie to the moon was appealing, no idea came close to combating unexpected medical debt for families," said Cineverse SVP of Marketing Lauren McCarthy. "The Toxic Avenger had his entire life upended by crushing medical costs so, as Toxie says, 'Sometimes you have to do something'."

Learn more about Undue Medical Debt with their explainer video and FAQ and then check out the official Toxic Avenger campaign page.

"As the medical debt crisis continues to grow we're grateful for this partnership with The Toxic Avenger film, which is not only funding debt relief but also shining a light on the human impact of a broken system," said Marisa Clemente, Vice President of Philanthropy at Undue Medical Debt. "We are always looking to team up with real-life superheroes who support our mission — including movie lovers, who now have an easy way to enjoy a reimagined classic while supporting financially and emotionally burdened families."

The nonprofit leverages donations to purchase qualifying medical debt (for individuals four times or below the federal poverty level or who have medical debt that is 5% or more of annual income) in bulk from providers like hospitals and also collection agencies for pennies on the dollar meaning one dollar donated, on average, erases $100 of un-payable medical debt. Recipients of debt relief then receive an Undue branded envelope in the mail out of the blue with the good news: some or all of their medical debt has been erased. Cineverse is relieving at least $5 million in medical debt across the country, where needed most.

THE TOXIC AVENGER
Premieres August 29, 2025
Run Time: 102 minutes | Rating: Not Rated

When a downtrodden janitor, Winston Gooze (Peter Dinklage), is exposed to a catastrophic toxic accident, he's transformed into a new kind of hero: The Toxic Avenger. Now, Toxie must rise from outcast to savior, taking on ruthless corporate overlords and corrupt forces who threaten his son, his friends, and his community. In a world where greed runs rampant… justice is best served radioactive.

WRITTEN AND DIRECTED BY: Macon Blair

BASED ON: Lloyd Kaufman's "THE TOXIC AVENGER"

PRODUCER: Legendary Entertainment

DISTRIBUTOR: Cineverse

CAST INCLUDES: Peter Dinklage, Kevin Bacon (Footloose, Hollow Man), Elijah Wood (The Lord of the Rings franchise), Jacob Tremblay (Room, Wonder), and Taylour Paige (Beverly Hills Cop: Axel F, Zola).

OFFICIAL RED BAND TRAILER

*TOXIE ON SOCIAL:
Instagram
X
Facebook
TikTok
BlueSky

About Undue Medical Debt

Undue Medical Debt is a national 501(c)(3) nonprofit founded in 2014 by former debt collectors. To date Undue has acquired — and abolished — over $22 billion of burdensome medical debt, helping over 14 million families and addressing a major social determinant of health. Undue purchases unpayable debts for a fraction of their face value in bundled portfolios and partners with individuals, faith-based organizations, local and state governments, foundations, corporations and many others to empower donors by converting every dollar contributed into $100 of medical debt relief on average.

Undue partners with hospitals, health systems and physician groups to acquire medical debt for abolishment. Undue rose to national prominence on an episode of HBO's "Last Week Tonight" with John Oliver in which Undue facilitated the abolishment of $15M in medical debt. To learn more, visit: https://unduemedicaldebt.org/

About Cineverse Motion Pictures Group

Cineverse super-serves passionate audiences by distributing content across all windows and platforms, from theatrical to digital to physical. Following the breakout box office success of Terrifier 3, upcoming releases include the franchise expansions of The Toxic Avenger (August 29, 2025) and Silent Night, Deadly Night (December 12, 2025). Coming in 2026 include its first kids and family theatrical release, Air Bud Returns, as well as Return to Silent Hill (January 23, 2026) and  Wolf Creek: Legacy, with more to be announced soon.

About Cineverse

Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences and results for its partners with unprecedented efficiency, and distributes more than 71,000 premium films, series, and podcasts. Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing non-rated film in U.S. history; dozens of streaming fandom channels; a premier podcast network; top horror destination Bloody Disgusting; and more. Powering visionary storytelling with cutting-edge innovation, Cineverse's proprietary streaming tools and AI technology drive revenue and reach to redefine the next era of entertainment. For more information, visit home.cineverse.com.

Contacts:

Cineverse
For Media, The Lippin Group for Cineverse
[email protected]

For Investors, Julie Milstead
[email protected]

Undue Medical Debt
[email protected]

SOURCE Cineverse Corp.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Cineverse Technology Group Launches Matchpoint™ 3.0 with New Features, Brand Identity

Cineverse Technology Group Launches Matchpoint™ 3.0 with New Features, Brand Identity

Cineverse Corp (Nasdaq: CNVS), a next-generation entertainment studio, has today launched Matchpoint™ 3.0, the newest version of the Company's...

Cineverse Slashes Into the Spooky Season with 31 Days of Halloween on SCREAMBOX -- Featuring a Killer Roster of Films and Series

Cineverse Slashes Into the Spooky Season with 31 Days of Halloween on SCREAMBOX -- Featuring a Killer Roster of Films and Series

Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, and Bloody Disgusting, its horror division, have announced that 31 Days of...

More Releases From This Source

Explore

Telecommunications Industry

Telecommunications Industry

Multimedia & Internet

Multimedia & Internet

Computer & Electronics

Computer & Electronics

Entertainment

Entertainment

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.